Metropolitan Hospital Center is a hospital in East Harlem, New York City. It has been affiliated with New York Medical College since it was founded in 1875, representing the oldest partnership between a hospital and a private medical school in the United States.

During the past decade, Metropolitan Hosp. NICHD CRS conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 6 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Metropolitan Hosp. NICHD CRS" #1 collaborator was "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 5 trials as a collaborator, "Bristol-Myers Squibb" with 2 trials as a collaborator, "AIDS Clinical Trials Group" with 1 trials as a collaborator, "Glaxo Wellcome" with 1 trials as a collaborator and "Hoffmann-La Roche" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Metropolitan Hosp. NICHD CRS" are "HIV Infections" (14 trials), "H1N1 Influenza Virus" (2 trials), "Measles" (1 trials) and "Meningitis" (1 trials). Many other conditions were trialed in "Metropolitan Hosp. NICHD CRS" in a lesser frequency.

Most popular intervention types in "Metropolitan Hosp. NICHD CRS" are "Drug" (10 trials) and "Biological" (4 trials). Other intervention types were less common.

The name of intervention was led by "Didanosine" (2 trials), "Stavudine" (2 trials), "Zalcitabine" (2 trials), "Zidovudine" (2 trials) and "Attenuvax" (1 trials). Other intervention names were less common.

The vast majority of trials in "Metropolitan Hosp. NICHD CRS" are 13 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Metropolitan Hosp. NICHD CRS". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in Metropolitan Hosp. NICHD CRS, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Metropolitan Hosp. NICHD CRS, 4 "Phase 1" clinical trials were conducted, 12 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".